KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $21.0 million.

  • Idexx Laboratories' Other Working Capital Changes fell 6715.64% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.3 million, marking a year-over-year increase of 133437.32%. This contributed to the annual value of $80.7 million for FY2024, which is 68957.02% up from last year.
  • As of Q3 2025, Idexx Laboratories' Other Working Capital Changes stood at $21.0 million, which was down 6715.64% from $129.6 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Other Working Capital Changes ranged from a high of $129.6 million in Q2 2025 and a low of -$40.2 million during Q2 2024
  • Its 5-year average for Other Working Capital Changes is $20.3 million, with a median of $15.3 million in 2022.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 227952.06% in 2022, then plummeted by 31236.73% in 2024.
  • Idexx Laboratories' Other Working Capital Changes (Quarter) stood at $3.2 million in 2021, then surged by 379.99% to $15.3 million in 2022, then crashed by 306.66% to -$31.6 million in 2023, then skyrocketed by 212.06% to $35.4 million in 2024, then crashed by 40.56% to $21.0 million in 2025.
  • Its Other Working Capital Changes stands at $21.0 million for Q3 2025, versus $129.6 million for Q2 2025 and $10.3 million for Q1 2025.